Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CMC Biologics, MacroGenics In Process Development Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

CMC Biologics, MacroGenics In Process Development Pact

CMC to manufacture oncology product candidate

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CMC Biologics, Inc. and MacroGenics, Inc., a clinical-stage biopharmaceutical company, have entered into an agreement to further develop the production process for transfer and clinical manufacture of an undisclosed MacroGenics’ oncology candidate.
 
“We look forward to working with MacroGenics to further develop and advance this immuno-oncology program,” said Gustavo Mahler, Ph.D., global chief operations officer of CMC Biologics. “This contract highlights CMC Biologics’ focus on working with our customers as partners and our capabilities in the development and clinical manufacturing of monoclonal antibodies.”
 
“We are impressed with CMC Biologics’ experience and technical competency in biopharmaceutical development and cGMP manufacturing,” said MacroGenics president and chief executive officer, Scott Koenig, MD, Ph.D. “Choosing a contract manufacturing partner with quality facilities that is able to provide flexible solutions and meet our clinical timelines is critical to realizing the potential of life-saving medicines.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics